Tatva Chintan Pharma Chem Cash Flow
- Market cap
- ₹4,194 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,290.82 – ₹2,420.28
In the year ended FY25, Tatva Chintan Pharma Chem generated ₹252 crore from operating activities, invested ₹168 crore and paid out ₹62.91 crore on financing activities. Net cash flow for the year was ₹20.97 crore. Free cash flow was ₹105 crore.
Tatva Chintan Pharma Chem cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 252 |
| Cash from investing activities | -168 |
| Cash from financing activities | -62.91 |
| Net cash flow | 20.97 |
| Capital expenditure | 147 |
| Free cash flow | 105 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Tatva Chintan Pharma Chem cash flow — frequently asked questions
What is Tatva Chintan Pharma Chem's operating cash flow?
Tatva Chintan Pharma Chem's cash flow from operating activities was ₹252 crore in the year ended FY25.
What is Tatva Chintan Pharma Chem's free cash flow?
Tatva Chintan Pharma Chem's free cash flow — operating cash flow minus capital expenditure — was ₹105 crore in FY25, after capital expenditure of ₹147 crore.
How much did Tatva Chintan Pharma Chem spend on investing activities?
Net cash used in investing activities was ₹168 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Tatva Chintan Pharma Chem With ATS
Track TATVA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.